Endophthalmitis
Therapeutic area
Infectious Disease
Rare disease
Yes
- Definition
- An infectious process affecting the internal structures of the eye.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Endophthalmitis
- Alternative names
- endophthalmitis
- Therapeutic area
- Infectious Disease
- Severity
- Severe
- Acquired
- Inflammatory
- Infectious Disease
- Ophthalmology
- MONDO ID
- MONDO:0016047
- Parent condition
- MONDO:0021166
Related records
Broader conditions (12)
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Disorder of orbital region
- Disorder of visual system
- Eye disorder
- Eye infectious disorder
- Human disease
- Infectious disease
- Inflammatory disease
Narrower conditions (24)
- Acanthamoeba keratitis
- Acute endophthalmitis
- Chronic endophthalmitis
- Corneal abscess
- Corneal infection
- Cytomegalovirus retinitis
- Endotheliitis
- Epidemic keratoconjunctivitis
- Fungal keratitis
- Gonococcal endophthalmia
- Gonococcal iridocyclitis
- Gonococcal keratitis
- Herpes simplex virus keratitis
- Histoplasmosis retinitis
- Hypopyon
- Hypopyon ulcer
- Infectious anterior uveitis
- Infectious epithelial keratitis
- Infectious posterior uveitis
- Panophthalmitis
Trials (57)
- A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
- A Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022
- Bromfenac Versus Dexamethasone After Cataract Surgery
- Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain
- Clinical Features and Visual Prognosis of Infectious Endophthalmitis
- Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
- Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora
- Complex Ocular Infection, Optimization of Microbiological Diagnosis
- Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection
- Conjunctival Flora Before Cataract Surgery: a Microbiological Evaluation
- Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
- Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections
- Early Vitrectomy for Endophthalmitis After Cataract Surgery
- Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery
- Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery
- Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024
- Endogenous Endophthalmitis in the Inpatient Setting
- Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics
- Endophthalmitis Cultures
- Endophthalmitis Post Intravitreal Injections
Drugs in development (4)
- Cefuroxime Phase 1
- Ciprofloxacin Phase 2
- Levofloxacin Phase 1
- Moxifloxacin Phase 3
Other linked drugs (2)
- Gatifloxacin
- Sodium chloride